Xilio Therapeutics
32 hedge funds and large institutions have $51M invested in Xilio Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 0 closing their positions.
Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.51%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
6
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
RSCM
1
Rock Springs Capital Management
Baltimore,
Maryland
|
$4.57M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$228K |
3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$56.9K |
4 |
4
Morgan Stanley
New York
|
$96.8K |
5 |
5
Northern Trust
Chicago,
Illinois
|
$53.6K |
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$60K |
2 |
2
Millennium Management
New York
|
$53K |
3 |
3
Bank of America
Charlotte,
North Carolina
|
$720K |